WHITE ROBERT S.
Known title: DirectorCIK: 0001571208
Associated companies
Transaction History
| ATRC | ▲ Buy | Grant | 6,144 | $0 | 5/18/2026 | View on chart |
| ATRC | ▲ Buy | Option Exercise | 10,000 | $150K | 3/10/2026 | View on chart |
| ATRC | ▲ Buy | Grant | 5,401 | $0 | 5/19/2025 | View on chart |
| ATRC | ▲ Buy | Option Exercise | 10,000 | $226K | 5/5/2025 | View on chart |
| ATRC | ▲ Buy | Grant | 7,788 | $0 | 5/13/2024 | View on chart |
| ATRC | ▲ Buy | Option Exercise | 10,000 | $160K | 2/23/2024 | View on chart |
| ATRC | ▲ Buy | Grant | 3,186 | $0 | 5/25/2023 | View on chart |
| ATRC | ▲ Buy | Option Exercise | 20,000 | $170K | 2/27/2023 | View on chart |
| ATRC | ▲ Buy | Option Exercise | 15,000 | $127K | 8/31/2022 | View on chart |
| ATRC | ▲ Buy | Grant | 3,564 | $0 | 5/25/2022 | View on chart |
| ATRC | ▲ Buy | Option Exercise | 15,000 | $127K | 3/3/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 13, 2026
BTIG raises AtriCure price target to $63
BTIG raised its price target on AtriCure to $63. The new target sits above the current analyst consensus of $54.89 and exceeds the stock’s recent 52‑week high of $61.70. This adjustment may influence market expectations as the company trades near its recent support level of $27.47.
BTIG raises AtriCure price target to $63. BTIG raised its price target on AtriCure to $63. The new target sits above the current analyst consensus of $54.89 and exceeds the stock’s recent 52‑week high of $61.70. This adjustment may influence market expectations as the company trades near its recent support level of $27.47.